MedTrace Logo

Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry

NCT04945005 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2021-06-30

No results posted yet for this study

Summary

Registry for patients undergoing pacemaker/ICD implantation including a transtricuspid lead with and without intraprocedural transesophageal echocardiography to evaluate risk factors for lead induced tricuspid regurgitation.

Conditions

  • Tricuspid Valve Insufficiency
  • Pacemaker Complication
  • Echocardiography, Transesophageal

Interventions

PROCEDURE

Transesophageal guidance of lead implantation

In patients undergoing lead implantation including transesophageal echocardiography for clinical reasons (e.g. intraprocedural cardioversion), echocardiography was also used for guidance of lead implantation to reduce lead-leaflet interactions

Sponsors & Collaborators

  • LMU Klinikum

    lead OTHER

Principal Investigators

  • Daniel Braun, PD Dr. med. · LMU Klinikum

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04945005 on ClinicalTrials.gov